The Oncology Institute Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Make Smarter Decisions with the Full Value Chain Report
This The Oncology Institute Value Chain Analysis gives a clear, structured view of the company's support activities and primary activities, helping you assess how it creates value. The page already shows a real preview of the actual analysis, so you can review the content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
The Oncology Institute's firm infrastructure centers on finance, compliance, revenue-cycle, and payer-contracting teams, which is critical for a multi-site oncology model. In FY2025, that setup helps keep clinic operations standardized, reduce reimbursement leakage, and shift more local staff time to patient care. It also matters because oncology margins stay tight, so even small billing or contract wins can lift cash flow across the network.
Human Resource Management
The Oncology Institute's Human Resource Management hinges on hiring and keeping oncologists, radiation specialists, nurses, medical assistants, and care coordinators. Training and scheduling are critical because cancer care needs stable teams, consistent protocols, and fast patient access. In 2025, labor scarcity in U.S. health care kept wage pressure high, so retention and cross-training stayed central to service quality.
Technology Development
The Oncology Institute uses electronic health records, clinical systems, and analytics to link medical oncology, radiation oncology, hematology, surgical oncology, and supportive care. In outpatient care, this improves documentation, speeds follow-up, and helps teams keep treatment plans aligned across sites. Better data flow also supports lower admin friction and tighter coordination for complex cancer cases.
Procurement
The Oncology Institute's procurement must lock in favorable terms for oncology drugs, infusion supplies, diagnostics, and equipment, because drug mix and vendor pricing can move margins fast. Strong supplier control also matters for treatment continuity: even one stockout can disrupt infusion schedules and patient care. In 2025, tighter spend discipline is still a key lever for protecting cash and operating margin.
The Oncology Institute's Back-Office Engine Protects Margin and Care Quality
In FY2025, The Oncology Institute's support activities mainly protect margin and care quality through tight finance, HR, IT, and procurement control. Central billing and payer work help limit reimbursement leakage, while hiring and retention keep scarce oncology staff in place. Shared clinical systems improve handoffs, and disciplined sourcing helps avoid drug and supply disruptions.
| Support activity | Value driver |
|---|---|
| Finance | Cash and margin control |
| HR | Retention and staffing |
| IT | Coordination and speed |
| Procurement | Supply continuity |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
In fiscal 2025, The Oncology Institute's inbound logistics began with patient referrals, medical records, lab results, imaging, and insurance verification before treatment starts.
It also included receiving infusion drugs and supportive-care supplies at local clinics, which helps keep pharmacy flow tight and lowers delays.
This setup matters because oncology care often needs fast intake, with treatment timing tied to lab and imaging review.
Operations
The Oncology Institute creates value by diagnosing, planning, and delivering integrated cancer care through medical oncology, radiation oncology, hematology, surgical oncology coordination, and supportive care in community clinics. In 2025, it continued to scale that model across a multi-state network, which helps keep treatment close to patients and lowers friction in care delivery. This setup supports faster referrals, tighter care coordination, and more consistent treatment plans for complex cases.
Outbound Logistics
The Oncology Institute's outbound logistics is the patient handoff after treatment: scheduled visits, transfers between local clinics, and follow-up records sent to patients and referring providers. This matters because coordinated discharge and referral flow cuts missed visits, travel burden, and therapy delays across its clinic network. For patients with cancer, faster next-step coordination can be the difference between staying on plan and dropping off care.
Marketing and Sales
The Oncology Institute grows through physician referrals, payer contracts, and local trust, so marketing and sales are really about access and network reach. In 2025, the American Cancer Society estimated about 2.04 million new U.S. cancer cases, which keeps referral demand high and makes convenience and care coordination a real selling point. TOI's integrated model helps it show oncologists, PCPs, and payers that one-site care can improve continuity and lower friction.
Service
The Oncology Institute's Service activity extends care after treatment with monitoring, symptom control, patient education, and navigation. In a chronic-care cancer model, this lowers gaps in follow-up and helps keep patients engaged. It also supports adherence to next-step care plans, which can improve long-term outcomes.
This post-treatment layer is also a retention tool, since patients who keep using The Oncology Institute for follow-up care are more likely to stay in-network for future oncology needs.
The Oncology Institute Scales Community Cancer Care Amid 2.04M U.S. Cases
In fiscal 2025, The Oncology Institute's primary activities were diagnosing, treating, and following cancer patients through community clinics, with care plans built from referrals, labs, imaging, and payer checks. The model also used infusion, supportive care, and post-visit monitoring to keep treatment moving and reduce gaps.
| Primary activity | 2025 point |
|---|---|
| Care delivery | Multi-state clinic network |
| Demand backdrop | 2.04 million U.S. cases |
Full Version Awaits
The Oncology Institute Reference Sources
This is the actual The Oncology Institute Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so what you see here is exactly what you'll get. Purchase unlocks the complete, detailed version immediately after checkout.
Frequently Asked Questions
Operations drive it most. The Oncology Institute combines 4 support activities with 5 primary activities, and its care model spans 5 service lines: medical oncology, radiation oncology, hematology, surgical oncology, and supportive care. That makes scheduling, authorization, and care coordination more valuable than physical distribution or scale alone.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.